This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products ...

A jury ordered Abbott Laboratories to pay $495 million in compensation and damages after determining that the company failed ...

Blood sugar tracking is officially general-wellness territory. Abbott announced Thursday that its prescription-free continuous glucose monitor, Lingo, is now available for sale in the US.

This was the stock's third consecutive day of losses.

Brianna Abbott is a health reporter covering the treatment and prevention of disease, with a special focus on cancer, in The Wall Street Journal’s Health and Science bureau. She writes stories ...

Given its better prospects, we believe Abbott stock (NYSE: ABT) is a better pick than its peer Medtronic stock (NYSE: MDT). ABT stock trades at 4.9x trailing revenues, versus 3.6x for MDT.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $133.00. The company’s shares ...

Abbott Elementary: L-R: William Stanford Davis, Lisa Ann Walter, Tyler James Williams, Sheryl Lee Ralph, Chris Perfetti, Janelle James, Quinta Brunson (front/center) ABC EXCLUSIVE: ABC’s Abbott ...

Summary. In 2008 Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 million diabetes patients by offering continuous ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...